CD274 and endometrial cancer: Immunotherapy can now be used in microsatellite-unstable endometrial cancer patients regardless of the PD-L1 status and in cervical cancer patients in association with the PD-L1 status, while the important role of the immune microenvironment is constantly expanding in several gynecological conditions [19,20,21,22].